Consensus Statements From a Multidisciplinary Expert Panel on the Utilization and Application of a Liver-Specific Magnetic Resonance Imaging (MRI) Contrast Agent (Gadoxetic Acid) is organized by American Roentgen Ray Society (ARRS).

Date of issuance: February 20, 2015
Date of expiration: February 19, 2021
Estimated time to complete the activity: 1 hour(s)

Accreditation​​​​​​:
Designation Statement
The ARRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The ARRS designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™ and 1 American Board of Radiology©, MOC Part II, Self-Assessment CME (SA-CME.) Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Goals and Objectives:
After completing the material in this article, the learner should be able to:
To understand the incremental diagnostic value of hepatobiliary phase imaging with gadoxetic acid–enhanced liver MRI.

Additional details will be posted as soon as they are available.

• CME : 1

The target audience for this activity is readers of the AJR, radiologists, radiologists-in-training, and other health professionals with an interest in hepatic resection for malignancy.

Number of Health Care Professionals Registered: 0 Number